Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the US
Clinical trial NCT05260684 · COMPLETED
Trial details
- NCT number
- NCT05260684
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-17
- Primary completion
- 2023-12-31
- Enrollment
- 716
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.